Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
With semaglutide, total alcohol intake decreased by 1,550 g/30 days, compared with an approximate reduction of 1,026 g/30 days in the placebo group (estimated between-group difference of ~468 g/30 days), and the number of drinks per day decreased by 3.5 units
Long-Term Strategy: Semaglutide isnt a quick fix
A study with 6 participants (3 per group) is considered a pilot study it demonstrates that a concept is worth investigating further, but cannot prove that a treatment works
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications primarily used for managing type 2 diabetes and, in some formulations, for weight management in adults with BMI 30 kg/m or 27 kg/m with weight-related comorbidities
doi: 10.1056/NEJMoa2206038
US$ 27.08
US$ 22.73
US$ 27.18
US$ 21.37
